These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6190870)

  • 1. The use of pre-enrichment for the isolation of small numbers of gentamicin-resistant Providencia stuartii from faeces.
    Hawkey PM; Potten MR; Stephens M
    J Hosp Infect; 1982 Dec; 3(4):369-74. PubMed ID: 6190870
    [No Abstract]   [Full Text] [Related]  

  • 2. Providencia stuartii: a search for its natural habitat.
    Stickler DJ; Fawcett C; Chawla JC
    J Hosp Infect; 1985 Jun; 6(2):221-3. PubMed ID: 2862199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence and pathogenic role of Morganella-Proteus-Providencia group bacteria in human feces.
    Müller HE
    J Clin Microbiol; 1986 Feb; 23(2):404-5. PubMed ID: 3517057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Providencia isolated from the stools of patients with gastroenteritis].
    Berkman E
    Mikrobiyol Bul; 1976 Jul; 10(3):307-11. PubMed ID: 979696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Providencia stuartii: a common cause of antibiotic-resistant bacteriuria in patients with long-term indwelling catheters.
    Warren JW
    Rev Infect Dis; 1986; 8(1):61-7. PubMed ID: 3081988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dry medium with ampholan for isolation of Proteus and Providencia].
    Gaziumarova LD; Moroz AF; Ertuganova ZA; Afinogenov GE
    Lab Delo; 1978; (6):336-8. PubMed ID: 79680
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combined media for the simplified and rapid identification of bacteria of the Proteus-Providencia group].
    Kalina GP
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jan; (1):53-7. PubMed ID: 6340384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commercial identification systems often fail to identify Providencia stuartii.
    Cornaglia G; Dainelli B; Berlutti F; Thaller MC
    J Clin Microbiol; 1988 Feb; 26(2):323-7. PubMed ID: 3277997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antimicrobial susceptibilities of clinical isolates of Morganella-proteus-providencia group of bacteria].
    Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y
    Jpn J Antibiot; 1991 Feb; 44(2):140-9. PubMed ID: 2041155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Providencia stuartii infections: a review of 117 cases over an eight year period.
    McHale PJ; Walker F; Scully B; English L; Keane CT
    J Hosp Infect; 1981 Jun; 2(2):155-65. PubMed ID: 6174578
    [No Abstract]   [Full Text] [Related]  

  • 11. Media for the detection and recognition of the enteropathogen Providencia alcalifaciens in faeces.
    Senior BW
    J Med Microbiol; 1997 Jun; 46(6):524-7. PubMed ID: 9350207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Speciation, serotyping, antimicrobial sensitivity and plasmid content of Proteeae from the environment of calf-rearing units in South West England.
    Hawkey PM; Penner JL; Linton AH; Hawkey CA; Crisp LJ; Hinton M
    J Hyg (Lond); 1986 Dec; 97(3):405-17. PubMed ID: 3540110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isolation and characteristics of Providence group bacteria of the clinical origin].
    Kobayashi A; Kubo S; Araki M; Takazawa S; Hayashi K
    Rinsho Byori; 1974 Oct; 22(10 Suppl):344. PubMed ID: 4475932
    [No Abstract]   [Full Text] [Related]  

  • 14. Providencia stuartii, a hospital pathogen: potential factors for its emergence and transmission.
    Wenzel RP; Hunting KJ; Osterman CA; Sande MA
    Am J Epidemiol; 1976 Aug; 104(2):170-80. PubMed ID: 952286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to uroepithelial cells of Providencia stuartii isolated from the catheterized urinary tract.
    Mobley HL; Chippendale GR; Tenney JH; Warren JW
    J Gen Microbiol; 1986 Oct; 132(10):2863-72. PubMed ID: 3625167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spurious hydrogen sulfide production by Providencia and Escherichia coli species.
    Treleaven BE; Diallo AA; Renshaw EC
    J Clin Microbiol; 1980 Jun; 11(6):750-2. PubMed ID: 7000823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients.
    Johnson DE; Lockatell CV; Hall-Craigs M; Mobley HL; Warren JW
    J Urol; 1987 Sep; 138(3):632-5. PubMed ID: 3625871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: Providencia stuartii infections.
    Keane CT; English LF; Wise R
    Lancet; 1975 Nov; 2(7943):1045. PubMed ID: 53535
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation of Providencia heimbachae from human feces.
    Mohr O'Hara C; Steigerwalt AG; Green D; McDowell M; Hill BC; Brenner DJ; Miller JM
    J Clin Microbiol; 1999 Sep; 37(9):3048-50. PubMed ID: 10449504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Media and tests to simplify the recognition and identification of members of the Proteeae.
    Senior BW
    J Med Microbiol; 1997 Jan; 46(1):39-44. PubMed ID: 9003744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.